Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bind Therapeutics
Biotech
After Bind bankruptcy, Hirsch once again helms a biotech
Andrew Hirsch will now lead C4 Therapeutics after a tumultuous time at Bind.
Ben Adams
Sep 9, 2020 6:45am
Fierce 15: Where are they now?
Sep 16, 2019 8:00am
Cerulean is blue as it cuts half of staffers after cancer trial failure
Aug 19, 2016 6:16am
Biotech CEO confidence returns, but deal landscape still bleak
Aug 16, 2016 3:40am
Bankrupt biotech Bind eyes $20M sale to Pfizer
Jul 7, 2016 6:09am
Langer’s nanoparticle biotech Selecta Biosciences shoots for $75M IPO
May 25, 2016 4:44am
